Analysts Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $24.88

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have received a consensus rating of “Buy” from the eighteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $24.88.

Several research firms have recently issued reports on PRVA. Truist Financial upped their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. Macquarie initiated coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 price target on the stock. Barclays lifted their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. KeyCorp began coverage on Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price on the stock. Finally, JPMorgan Chase & Co. boosted their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $20.51 on Wednesday. The business’s 50-day moving average is $20.93 and its 200 day moving average is $19.47. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $23.24. The firm has a market capitalization of $2.46 billion, a P/E ratio of 205.12, a P/E/G ratio of 5.45 and a beta of 0.85.

Hedge Funds Weigh In On Privia Health Group

Large investors have recently made changes to their positions in the company. Canada Pension Plan Investment Board acquired a new stake in Privia Health Group during the second quarter valued at $26,000. GAMMA Investing LLC boosted its stake in shares of Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after acquiring an additional 845 shares in the last quarter. Quarry LP grew its position in shares of Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after acquiring an additional 2,533 shares during the period. KBC Group NV increased its stake in shares of Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares in the last quarter. Finally, Neo Ivy Capital Management acquired a new position in Privia Health Group in the 3rd quarter worth about $66,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.